Viewing nowOloPIDin Tablet 5 mg (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Genupharm Co., Ltd.

MFDS item code 200801763 · Notified 2008.02.13 · Insurance code 698003860
Relief of itching due to allergic rhinitis and skin conditions (such as eczema and dermatitis)
This medication is used in adults to relieve itching caused by allergic rhinitis, urticaria, and various skin conditions such as eczema, dermatitis, papular urticaria, atopic dermatitis, and psoriasis. It is also effective in improving itching due to allergic rhinitis, urticaria, eczema, and atopic dermatitis in children. Therefore, this medication helps treat allergy-related and skin-related itching across various age groups.
In general, adults should take 5 mg of Olopatadine Hydrochloride orally twice a day (morning and before bedtime). The dosage may be adjusted according to age and symptoms.
Children over 10 years old should take 5 mg of Olopatadine Hydrochloride orally twice a day (morning and before bedtime).
This medication contains lactose and should not be used by patients with genetic disorders that affect lactose digestion. It should be used with caution in patients with reduced kidney function, elderly patients, and those with liver function issues. These patients may retain the drug in their bodies longer, and there is a risk of liver function deterioration. While taking this medication, symptoms such as drowsiness, elevated liver enzymes, fatigue, dry mouth, and abdominal pain may occur. Serious side effects such as severe hepatitis, liver dysfunction, or jaundice can occur, so consult a doctor immediately if symptoms appear. Additionally, hypersensitivity reactions such as skin rashes or respiratory distress may occur, so if abnormal symptoms develop, stop taking the medication immediately and inform healthcare professionals. Avoid driving or operating dangerous machinery while taking this medication, as it may cause drowsiness. Patients undergoing long-term steroid treatment should gradually reduce their steroid dosage under medical supervision if taking this medication. For seasonal allergies, it is advisable to start taking this medication before symptoms begin and continue until symptoms resolve. If there is no effect, do not take it for an extended period. Pregnant women or those who may become pregnant should only take this medication if the benefits outweigh the risks, as safety has not been fully established. Nursing mothers are advised not to take this medication, and if it is necessary, they should stop breastfeeding. The safety of this medication has not been sufficiently established in children under 10 years, newborns, or premature infants, so its use should be avoided. Elderly patients may have reduced bodily functions, so it should be started at a low dose, with careful monitoring of their condition. This medication may interfere with allergy tests, so avoid taking it before allergy skin reaction tests. Keep this medication out of the reach of children, and avoid transferring it to other containers to prevent misuse or degradation of quality.
Drowsiness, fatigue, dry mouth, abdominal pain, headache, heaviness of the head, dizziness, numbness, decreased concentration, involuntary movements (facial, limbs, etc.), abdominal discomfort, diarrhea, nausea, constipation, stomatitis, cheilitis, sore throat, heartburn, increased appetite, vomiting, increased white blood cells, decreased white blood cells, increased eosinophils, decreased lymphocytes, hematuria, elevated BUN, positive urine protein, increased serum creatinine, urinary difficulties, frequent urination, palpitations, high blood pressure.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C.
Pale yellow round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlopatadine Hydrochloride 5mg
Tablet · Prescription medication
Genupharm Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.